Ledger.Open graph →
SEC Form D · Amendment · filed April 18, 2017

Lattice Biologics Ltd

Offering
$371K
Sold
$371K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SCOTTSDALE, AZ
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Catherine Thomas · Scottsdale, AZDirectorGuy Cook · Scottsdale, AZExec · DirectorDonald Mcinnes · Scottsdale, AZDirectorMario Stifano · Scottsdale, AZDirectorCheryl Farmer · Scottsdale, AZExec · DirectorMichael Keriakos · NEW YORK, NYDirectorMark R. Jarrell · New York, NYExec · DirectorRobert Dahl · Greenwich, CTExec · DirectorSteven Elkes · NEW YORK, NYDirectorEdward Van Brunt · Phoenix, AZDirectorMichael Spadafore · New York, NYDirectorAndrew Prozes · New York, NYExec · DirectorNinggang T. Chen · Vienna, VAExec · DirectorXiaoxue T. He · MCLEAN, VADirectorAkintoye Akindele · Ebene, O4Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗